In our previous studies, we developed a hexokinase 2 (HK2)-based test for detecting rare tumor cells in multiple body fluids (e.g., pleural effusion, urine, blood, and cerebrospinal fluid) and cancers13–16. Here, HK2 is linked to Pleural effusion.